Vandana Singh

Contributing Author

Recent Articles by Vandana Singh

5 hours	AnaptysBio Pushes Back Against Lawsuit Over Cancer Drug Jemperli Royalties ANAB GSK Benzinga
6 hours	Tilray Valuation Attractive With Strong Growth Overseas, Analyst Says TLRY Benzinga
6 hours	Bad News For Competitor Turns Into Big Win For ARS Pharma Stock AQST -37.04% SPRY +19.27% Benzinga
7 hours	Beta Bionics Key KPI Miss Targets, Analyst Flags Valuation Risks BBNX -37.04% Benzinga
7 hours	Aquestive Stock Slides After FDA Flags Issues With Allergy Drug Application AQST -37.04% SPRY +19.27% Benzinga
8 hours	Insmed Maps Aggressive 2026 As Newly Approved Lung Disease Drug Gains Traction, Pipeline Advances INSM Benzinga
9 hours	KalVista Details Early Sales, Prescriber Uptake For Newly Approved Rare Swelling Drug KALV +6.19% Benzinga
10 hours	Eli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight LLY Benzinga
Jan-08	Enliven Therapeutics Early Leukemia Drug Results Impress, Stock Soars NVS ELVN Benzinga
Jan-08	MoonLake Says FDA May Allow Skin Drug Filing Without New Trials, Stock Soars MRK MLTX Benzinga
Jan-08	Small-Cap Acrivon Highlights Tumor Shrinkage And Trial Progress Across Key Studies, Stock Falls ACRV Benzinga
Jan-08	What's Going With Cancer Biotech Erasca Stock On Thursday? RVMD ERAS ABBV Benzinga
Jan-08	Eupraxia Trial Data Shows Lasting Tissue Healing In Patients With Inflamed Esophagus EPRX Benzinga
Jan-08	Neogen's Raised Outlook Fuels Turnaround Hopes, Stock Soars NEOG Benzinga
Jan-08	InflaRx Plans Workforce Reduction, Targets Mid-2027 Cash Runway IFRX Benzinga
Jan-08	Immuneering Pancreatic Cancer Trial Touts Encouraging Survival Data, But Stock Moves Lower REGN IMRX Benzinga
Jan-08	Phathom's Early Numbers Show Sales Strength, Eyes 2026 Profitability PHAT Benzinga
Jan-07	Regeneron Just Moved From Underperform To Buy - Here's Why SNY REGN Benzinga

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.